Gaucher disease in Syrian children: common mutations identification and clinical futures

Gaucher disease in Syrian children: common mutations identification and clinical futures

BACKGROUND AND OBJECTIVES: Gaucher disease (GD) is caused by the deficiency of glucosidase beta acid (GBA). Three clinical forms of GD are available. Some mutations in the GBA gene have a high frequency in specific populations. The aim of this study was to analyze the characteristics of phenotypes a...

Full description

Bibliographic Details
Main Author:	Diana Alasmar
Format:	Article
Language:	English
Published:	King Faisal Specialist Hospital and Research Centre 2015-03-01
Series:	Annals of Saudi Medicine
Online Access:	https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2015.127

Similar Items

Managing Children with Gaucher Disease: Modern Clinical Recommendations
by: A. A. Baranov, et al.
Published: (2016-08-01)

Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India
by: Jayesh Sheth, et al.
Published: (2018-10-01)

Gaucher Disease
by: Guilherme Henrique Hencklain Fonseca, et al.
Published: (2007-03-01)

Gaucher′s disease
by: Vijay Bohra, et al.
Published: (2011-01-01)

GAUCHER’S DISEASE
by: O. S. Gundobina, et al.
Published: (2013-11-01)

Mutation analysis of gaucher patients in Taiwan
by: Li, Zheng Dao, et al.
Published: (1994)

Identification of risk features for complication in Gaucher’s disease patients: a machine learning analysis of the Spanish registry of Gaucher disease
by: Marcio M. Andrade-Campos, et al.
Published: (2020-09-01)

Molecular basis and clinical management of Gaucher disease
by: Maja Di Rocco, et al.
Published: (2013-02-01)

Gaucher Disease and the Synucleinopathies
by: Kathleen S. Hruska, et al.
Published: (2006-01-01)

Report of Four Children with Gaucher Disease and Review of Literature
by: Wajiha Maan, et al.
Published: (2016-08-01)

Identification of Modifier Genes in a Mouse Model of Gaucher Disease
by: Andrés D. Klein, et al.
Published: (2016-09-01)

Genetic and clinical characteristics of Filipino patients with Gaucher disease
by: Mary Anne D. Chiong, et al.
Published: (2018-06-01)

Prevalence of Gaucher’s Disease in a Hematology Outpatient Clinic
by: Bilal Aygun, et al.
Published: (2020-03-01)

Doença de Gaucher: uma desordem subdiagnosticada Gaucher Disease: an underdiagnosed disorder
by: Camila Simões Ferreira, et al.
Published: (2011-03-01)

Manifestações esqueléticas da doença de gaucher Skeletal manifestations in Gaucher's disease
by: Vinicius França de Mendonça, et al.
Published: (2001-06-01)

Lung Involvement in Gaucher Disease
by: Mahnaz Pejman Sani, et al.
Published: (2020-04-01)

Management algorithms for gaucher disease
by: Ayman Alhejazi, et al.
Published: (2020-01-01)

Enzyme replacement in Gaucher disease.
by: Ernest Beutler
Published: (2004-11-01)

Exodontia in patient with Gaucher's disease
by: Guacyra Machado Lisboa, et al.
Published: (2011-12-01)

Pulmonary involvement in Gaucher disease
by: Lucas de Pádua Gomes de Farias, et al.

Optimal therapy in Gaucher disease
by: Ozlem Goker-Alpan
Published: (2010-07-01)

Prevalence and management of Gaucher disease
by: Burrow TA, et al.
Published: (2011-06-01)

Hemorrhagic Aspects of Gaucher Disease
by: Hanna Rsenbaum
Published: (2014-10-01)

Splenic lipids in Gaucher's disease
by: N.G. Kennaway, et al.
Published: (1968-11-01)

Lipids of the spleen in Gaucher's disease
by: William D. Suomi, et al.
Published: (1965-04-01)

The structure of cerebrosides in Gaucher's disease*
by: G.V. Marinetti, et al.
Published: (1960-04-01)

A case of Gaucher disease
by: ZHANG Dali, et al.
Published: (2016-10-01)

Studies on the lipids of Gaucher's disease
by: Kennaway, Nancy G.
Published: (1967)

Gaucher disease: achievements and prospects
by: Rodion V. Ponomarev, et al.
Published: (2021-07-01)

Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease.
by: Hila Zigdon, et al.
Published: (2015-01-01)

Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry
by: Yann Nguyen, et al.
Published: (2020-02-01)

Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula
by: Giraldo Pilar, et al.
Published: (2012-03-01)

Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups
by: Ju-Young Lee, et al.
Published: (2012-02-01)

A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
by: Jérôme Stirnemann, et al.
Published: (2017-02-01)

Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease
by: Ari Zimran, et al.
Published: (2018-02-01)

High frequency of mutation G377S in Brazilian type 3 Gaucher disease patients
by: R. Rozenberg, et al.
Published: (2006-09-01)

Homozygous N396T mutation in Gaucher disease: Portuguese sisters with markedly different phenotypes
by: Samantha Kimball, et al.
Published: (2011-03-01)

Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collaborative Gaucher Group Gaucher Registry
by: Jennifer Ibrahim, et al.
Published: (2016-09-01)

Association Between Progranulin and Gaucher Disease
by: Jinlong Jian, et al.
Published: (2016-09-01)

Synchronous multiple myeloma and Gaucher disease
by: Jorge Monge, et al.
Published: (2020-03-01)